Research Paper
Year: 2020 | Month: December | Volume: 7 | Issue: 12 | Pages: 178-183
Analysis of Cost-Effectiveness Use of Antibiotics Patients with Pulmonary TB Outpatient at Royal Prima Medan Hospital in 2018
Noni1, Ermi Girsang2, Chrismis Novalinda Ginting3, Riyani Susan Bt Hasan4
1Postgraduate Students Department Magister of Public Health, Faculty of Medicines at University Prima, Indonesia
2,3,4Postgraduate Lecturer Department Magister of Public Health, Faculty of Medicines at University Prima,
Indonesia
Corresponding Author: Ermi Girsang [Email: ermigirsang@unprimdn.ac.id]
ABSTRACT
India, Indonesia and China are the countries with the highest number of tuberculosis cases, which are 23%, 10% and 10% of all cases in the world. Selection of antibiotics that are inappropriate for therapy and irrational use of antibiotics can increase patients without hospitals and government. With the selection of antibiotics with relatively high costs, the effectiveness of the patient's therapy can be approved. This study was aimed to determine the cost-effectiveness of antibiotic use in pulmonary TB patients treated at the Royal Prima Hospital Medan in 2018. This study is an observational or non-experimental study of 46 medical records as samples (respondents), data collected as data patient's general characteristics, type and category of TB drugs, and direct medical costs. Then the data was analyzed with SPSS and agreed on cost-effectiveness of both OAT dosage forms. The results of this study indicate the direct medical research costs of pulmonary TB patients at the Royal Prima Medan Hospital in 2018 amounting to Rp 220,000.00 for action costs, Rp 350,000.00 for doctor services costs, and OAT costs of Rp 1,142,550.00. The cost (P value = 0.973) and effectiveness (P value = 0.665) was not different significantly between each group of respondents who received the FDC and Separated dosage. There is no difference in cost effectiveness between the two forms of TB drugs preparation.
Keywords: Pulmonary TB, Separated Dosage, TB Drug, FDC, Direct Medical Costs, Cost Effectiveness.
[PDF Full Text]